The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation

Bożena Szyguła-Jurkiewicz; Michał Zakliczyński; Mariusz Andrejczuk; Mateusz Mościński; Marian Zembala

doi:10.5114/kitp.2014.43847

eISSN: 1897-4252
ISSN: 1731-5530

Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

2/2014
vol. 11

Send email

Copy url:

abstract:

The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation

Bożena Szyguła-Jurkiewicz

,

Michał Zakliczyński

,

Mariusz Andrejczuk

,

Mateusz Mościński

,

Marian Zembala

Kardiochirurgia i Torakochirurgia Polska 2014; 11 (2): 178-181

DOI: https://doi.org/10.5114/kitp.2014.43847

Online publish date: 2014/06/30

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Szyguła-Jurkiewicz B, Zakliczyński M, Andrejczuk M, Mościński M, Zembala M. The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery. 2014;11(2):178-181. doi:10.5114/kitp.2014.43847.

APA

Szyguła-Jurkiewicz, B., Zakliczyński, M., Andrejczuk, M., Mościński, M.,  & Zembala, M. (2014). The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery, 11(2), 178-181. https://doi.org/10.5114/kitp.2014.43847

Chicago

Szyguła-Jurkiewicz, Bożena, Michał Zakliczyński, Mariusz Andrejczuk, Mateusz Mościński,  and Marian Zembala. 2014. "The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation". Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery 11 (2): 178-181. doi:10.5114/kitp.2014.43847.

Harvard

Szyguła-Jurkiewicz, B., Zakliczyński, M., Andrejczuk, M., Mościński, M.,  and Zembala, M. (2014). The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery, 11(2), pp.178-181. https://doi.org/10.5114/kitp.2014.43847

MLA

Szyguła-Jurkiewicz, Bożena et al. "The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation." Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery, vol. 11, no. 2, 2014, pp. 178-181. doi:10.5114/kitp.2014.43847.

Vancouver

Szyguła-Jurkiewicz B, Zakliczyński M, Andrejczuk M, Mościński M, Zembala M. The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation. Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery. 2014;11(2):178-181. doi:10.5114/kitp.2014.43847.

PlumX metrics:

Risk stratification in heart failure (HF) patients is an important element for management. There are several risk stratification models that can be used to predict the prognosis of patients with HF, such as Aaronson’s scale, CVM-HF (CardioVascular Medicine Heart Failure), the Seattle Heart Failure Model (SHFM) and the Munich score. These models fail to adequately address the impact of multiorgan dysfunction on prognosis.

The classical Model for End-Stage Liver Disease (MELD) score consists of: total bilirubin, INR (international normalized ratio) and creatinine level. There are some modifications of the MELD scale: MELD-XI, which excludes the INR score; the modMELD score, in which INR is replaced with albumin levels; and MELD-Na, which consists of the bilirubin and creatinine levels, INR ratio and the sodium level. Therefore, the MELD score systems are markers of multisystem dysfunction (renal, cardiac, hepatic). It is important that they are composed of routinely collected laboratory measures which are easy to use.

keywords:

The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation

Bożena Szyguła-Jurkiewicz , Michał Zakliczyński , Mariusz Andrejczuk , Mateusz Mościński , Marian Zembala

chronic heart failure, prognosis, MELD scale

Bożena Szyguła-Jurkiewicz

,

Michał Zakliczyński

,

Mariusz Andrejczuk

,

Mateusz Mościński

,

Marian Zembala